INBIOGEN CO.,Ltd Logo

INBIOGEN CO.,Ltd

Data mining, bioinformatics, and virtual assistance for the life sciences industry.

101140 | KO

Overview

Corporate Details

ISIN(s):
KR7101140002
LEI:
Country:
South Korea
Address:
서울특별시 강남구 언주로135길 21 2층(논현동), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Inbiogen is a life sciences company focused on providing virtual assistance and data mining services to the biotechnology and pharmaceutical industries. The company leverages a team of scientists and bioinformatics specialists to offer a range of services, including bioinformatics analysis, protein modeling, custom database development, and virtual research assistance. It aims to help international biotech companies and research organizations address challenges by extracting valuable knowledge from large datasets. In addition to its core scientific services, Inbiogen also provides marketing assistance and web design and development tailored to the life sciences sector, focusing on delivering customized and cost-effective solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 749.8 KB
2025-07-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 85.5 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 831.3 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.4 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.0 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 12.4 KB
2025-03-21 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 395.1 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 19.5 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 148.6 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 115.1 KB
2025-03-12 00:00
Earnings Release
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 20.0 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 12.3 KB
2025-01-22 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.6 KB
2025-01-10 00:00
Regulatory News Service
[기재정정]사업보고서 (2022.12)
Korean 442.9 KB
2025-01-10 00:00
Regulatory News Service
[기재정정]사업보고서 (2023.12)
Korean 1.1 MB

Automate Your Workflow. Get a real-time feed of all INBIOGEN CO.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INBIOGEN CO.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INBIOGEN CO.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.